News

Friday, September 2, 2016

ESC: IV Stem Cells for Heart Failure: ‘A Lot More to Learn’

MPT

Intravenous infusion of mesenchymal stem cells failed to improve cardiac function in heart failure patients but the treatment did appear to give patients some benefits such as improvement in physical tests, researchers said here. … In a Hot Line presentation here, Butler said that patients did show improvements in secondary endpoints – including the 6-minute walk test, in which those patients who received the stem cells had a 36-meter increase compared with placebo (P=0.02). READ FULL ARTICLE